We are live on ! Find out more
OWP

Old Well Partners Portfolio holdings

AUM $4.55M
1-Year Est. Return 27.75%
This Fund
S&P 500
This Quarter Est. Return
-10.45%
1 Year Est. Return
+27.75%
3 Year Est. Return
+97.85%
5 Year Est. Return
+345.65%
10 Year Est. Return
–
AUM
$162M
AUM Growth
-$32.1M
Cap. Flow
-$5.02M
Cap. Flow %
-3.1%
Top 10 Hldgs %
60.16%
Holding
56
New
16
Increased
3
Reduced
11
Closed
15

Top Buys

Rank Stock Value
1
NTES icon
NetEase
NTES
+$10.4M
2
OZON
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
+$8.85M
3
NU icon
Nu Holdings
NU
+$7.01M
4
BEKE icon
KE Holdings
BEKE
+$5.94M
5
DLO icon
dLocal
DLO
+$5.04M

Top Sells

Rank Stock Value
1
TSM icon
TSMC
TSM
+$7.48M
2
GDS icon
GDS Holdings
GDS
+$7.01M
3
STNE icon
StoneCo
STNE
+$6.3M
4
XP icon
XP
XP
+$5.57M
5
FUTU icon
Futu Holdings
FUTU
+$5.31M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 36.45%
2 Technology 20.12%
3 Healthcare 11.72%
4 Financials 10.94%
5 Communication Services 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRUS
26
DELISTED
Merus
MRUS
$240K 0.15%
+7,532
New +$213K
ITOS
27
DELISTED
iTeos Therapeutics
ITOS
$237K 0.15%
+5,096
New +$170K
KOD icon
28
Kodiak Sciences
KOD
$2.62B
$221K 0.14%
+2,601
New +$265K
RNAM
29
DELISTED
Avidity Biosciences
RNAM
$203K 0.13%
8,548
– –
SNCE
30
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$178K 0.11%
+715
New +$159K
RAIN
31
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$172K 0.11%
13,383
– –
JBIO
32
Jade Biosciences
JBIO
$1.21B
$149K 0.09%
360
– –
TYRA icon
33
Tyra Biosciences
TYRA
$1.85B
$148K 0.09%
+10,500
New +$209K
FOLD
34
DELISTED
Amicus Therapeutics
FOLD
$136K 0.08%
11,800
– –
TNGX icon
35
Tango Therapeutics
TNGX
$4.35B
$126K 0.08%
11,554
– –
VYGG.WS
36
DELISTED
Vy Global Growth Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
VYGG.WS
$115K 0.07%
98,914
– –
JYAC
37
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
$113K 0.07%
11,547
– –
ARYD
38
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$111K 0.07%
11,174
– –
CLYM
39
Climb Bio
CLYM
$732M
$108K 0.07%
+10,300
New +$154K
LIAN
40
DELISTED
LianBio American Depositary Shares
LIAN
$72K 0.04%
+11,700
New +$134K
ATXS
41
DELISTED
Astria Therapeutics
ATXS
$65K 0.04%
12,116
– –
ASND icon
42
Ascendis Pharma A/S
ASND
$16.6B
– –
-1,347
Closed -$215K
CNTB
43
Connect Biopharma Holdings
CNTB
$132M
– –
-122,431
Closed -$2.97M
FRSH icon
44
Freshworks
FRSH
$2.99B
– –
-5,000
Closed -$213K
FUTU icon
45
Futu Holdings
FUTU
$14.6B
– –
-58,300
Closed -$5.31M
GDS icon
46
GDS Holdings
GDS
$6.29B
– –
-123,900
Closed -$7.01M
PRTA icon
47
Prothena Corp
PRTA
$455M
– –
-4,824
Closed -$344K
SLDB icon
48
Solid Biosciences
SLDB
$777M
– –
-2,261
Closed -$81K
STNE icon
49
StoneCo
STNE
$2.65B
– –
-181,394
Closed -$6.3M
TSM icon
50
TSMC
TSM
$2.07T
– –
-67,000
Closed -$7.48M
1
2
3

Similar funds

TC
Tarsadia Capital New York $5.64M AUM 15.7% 1-Year Est. Return
MECA
Miller Equity Capital Advisors Irving, Texas $1.45M AUM 7.67% 1-Year Est. Return
SC
Spinnaker Capital Boston, Massachusetts $1.08M AUM 45.28% 1-Year Est. Return
EAM
Exos Asset Management New York $2.32K AUM 108.13% 1-Year Est. Return
GDCML
Galaxy Digital Capital Management LP New York $13.5M AUM
NTIMCH
New Thinking Investment Management Company (HK) Hong Kong $20.4M AUM 4.24% 1-Year Est. Return
SFAM
Springhill Fund Asset Management Hong Kong $20.9M AUM
FGN
Foundry Group Next Boulder, Colorado $21.1M AUM 35.51% 1-Year Est. Return

Old Well Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Old Well Partners held 56 positions worth $162M, down 17% from $194M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Old Well Partners withdrew a net $5.02M in Q4 2021, closing 15 positions and reducing 11 holdings. Its most notable exit was TSMC, an estimated $7.48M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 36% of assets, down from 38% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Old Well Partners opened a new position in NetEase worth $10.4M.

  • Old Well Partners's largest Q4 2021 buy was NetEase: 102,285 shares worth $10.4M.
  • Old Well Partners added most to Block Inc in Q4 2021, an estimated $1.19M increase.
  • Old Well Partners's biggest Q4 2021 reduction was NovaBridge Biosciences American Depositary Shares, cutting an estimated $3.46M.
  • Old Well Partners fully exited TSMC in Q4 2021, selling an estimated $7.48M.
  • Old Well Partners's ten largest holdings make up 60% of its $162M portfolio in Q4 2021.
  • Old Well Partners opened 16 new positions and closed 15 in Q4 2021.
  • Old Well Partners's portfolio value fell 17% quarter-over-quarter to $162M.

Based on Old Well Partners's 13F filing for Q4 2021, filed 14 Feb 2022.